Page last updated: 2024-10-21

phenytoin and Multiple Myeloma

phenytoin has been researched along with Multiple Myeloma in 12 studies

Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.

Research Excerpts

ExcerptRelevanceReference
"The occurrence of multiple myeloma is described in a patient receiving phenytoin (diphenylhydantoin) for 43 years."8.79[Multiple myeloma associated with phenytoin (diphenylhydantoin) therapy]. ( Dobashi, H; Inada, T; Kanoh, T, 1996)
"We report a case of multiple myeloma in a 48-year-old woman treated with phenytoin for 55 months."7.66Multiple myeloma after phenytoin therapy. ( Aymard, JP; Colomb, JN; Faure, G; Guerci, O; Herbeuval, R; Lederlin, P; Witz, F, 1981)
"The occurrence of multiple myeloma is described in a patient receiving phenytoin (diphenylhydantoin) for 43 years."4.79[Multiple myeloma associated with phenytoin (diphenylhydantoin) therapy]. ( Dobashi, H; Inada, T; Kanoh, T, 1996)
"We report a case of multiple myeloma in a 48-year-old woman treated with phenytoin for 55 months."3.66Multiple myeloma after phenytoin therapy. ( Aymard, JP; Colomb, JN; Faure, G; Guerci, O; Herbeuval, R; Lederlin, P; Witz, F, 1981)
"A hospital-based case-control study of multiple myeloma in whites (100 cases and 100 controls from seven Baltimore hospitals) was conducted to examine a number of postulated risk factors."1.27A case-control study of multiple myeloma in whites: chronic antigenic stimulation, occupation, and drug use. ( Harlow, SD; Linet, MS; McLaughlin, JK, 1987)
"The occurrence of angioimmunoblastic lymphadenopathy, Hodgkin's disease or IgG-lambda multiple myeloma is described in four patients receiving chronic diphenylhydantoin (DILANTIN) therapy."1.26Lymphoproliferative disorders in four patients receiving chronic diphenylhydantoin therapy: etiologic correlation or chance association? ( Matzner, Y; Polliack, A, 1978)

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-199011 (91.67)18.7374
1990's1 (8.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aymard, JP1
Lederlin, P1
Witz, F1
Colomb, JN1
Faure, G1
Guerci, O1
Herbeuval, R1
Kanoh, T1
Dobashi, H1
Inada, T1
Matzner, Y3
Polliack, A3
Jones, SN1
Stoker, DJ1
Linet, MS1
Harlow, SD1
McLaughlin, JK1
Friedman, GD1
Markkanen, T2
Himanen, P1
Pajula, RL1
Molnár, G1
Potolsky, A1
Creger, WP1
Keane, PM1
Pegg, PJ1
Johnson, E1
Peltola, O1

Reviews

1 review available for phenytoin and Multiple Myeloma

ArticleYear
[Multiple myeloma associated with phenytoin (diphenylhydantoin) therapy].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1996, Volume: 37, Issue:3

    Topics: Aged; Anticonvulsants; Humans; Male; Multiple Myeloma; Phenytoin

1996

Other Studies

11 other studies available for phenytoin and Multiple Myeloma

ArticleYear
Multiple myeloma after phenytoin therapy.
    Scandinavian journal of haematology, 1981, Volume: 26, Issue:4

    Topics: Female; Humans; Immunity, Cellular; Immunoglobulins; Middle Aged; Multiple Myeloma; Phenytoin

1981
Myelomatosis after phenytoin therapy: a chance association?
    Scandinavian journal of haematology, 1978, Volume: 21, Issue:4

    Topics: Agammaglobulinemia; Bone Neoplasms; Humans; Immunoglobulin G; Immunoglobulin lambda-Chains; Male; Mi

1978
Lymphoproliferative disorders in four patients receiving chronic diphenylhydantoin therapy: etiologic correlation or chance association?
    Israel journal of medical sciences, 1978, Volume: 14, Issue:8

    Topics: Adult; Female; Hodgkin Disease; Humans; Immunoblastic Lymphadenopathy; Lymphoproliferative Disorders

1978
Monoclonal gammopathy and subsequent multiple myeloma in a patient on chronic diphenylhydantoin therapy.
    Israel journal of medical sciences, 1978, Volume: 14, Issue:12

    Topics: Epilepsy; Humans; Male; Middle Aged; Multiple Myeloma; Phenytoin

1978
Radiology at your fingertips; lesions of the terminal phalanx.
    Clinical radiology, 1988, Volume: 39, Issue:5

    Topics: Bone Cysts; Bone Diseases; Bone Neoplasms; Carcinoma, Bronchogenic; Chondroma; Epidermal Cyst; Finge

1988
A case-control study of multiple myeloma in whites: chronic antigenic stimulation, occupation, and drug use.
    Cancer research, 1987, Jun-01, Volume: 47, Issue:11

    Topics: Asbestos; Humans; Hypersensitivity; Interviews as Topic; Multiple Myeloma; Occupational Diseases; Ph

1987
Multiple myeloma: relation to propoxyphene and other drugs, radiation and occupation.
    International journal of epidemiology, 1986, Volume: 15, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Colchicine; Dextropropoxyphene; Follow-Up Studies; Humans; Male; Mid

1986
Binding of folic acid to serum proteins. II. The effect of diphenylhydantoin treatment and of various diseases.
    Acta haematologica, 1973, Volume: 50, Issue:5

    Topics: Adolescent; Adult; Aged; Blood Proteins; Chromatography, Ion Exchange; Dextrans; Epilepsy; Fatty Aci

1973
Radiation and drug therapies, and leukemia.
    Annual review of medicine, 1973, Volume: 24

    Topics: Antineoplastic Agents; Benzene; Bone Marrow Diseases; Chloramphenicol; Cyclophosphamide; Dose-Respon

1973
Estimation of thyroxine binding protein capacities using a non-electrophoretic technique.
    The Journal of clinical endocrinology and metabolism, 1969, Volume: 29, Issue:8

    Topics: Barbiturates; Blood Protein Electrophoresis; Buffers; Cholestasis; Female; Humans; Multiple Myeloma;

1969
Pentose-phosphate pathway of leucocytes.
    Acta haematologica, 1971, Volume: 46, Issue:1

    Topics: Adult; Aged; Alcoholism; Anemia, Aplastic; Arthritis, Rheumatoid; Asthma; Diabetes Mellitus; Female;

1971